The European landscape is witnessing a unique evolution in the understanding of psychedelics. Long stigmatized, these substances have begun to gain traction for their medical applications. From Switzerland, where clinical trials are in progress, to the UK, where awareness is growing, Europe plays a leading role in this transformation of copyright c